Related Experiment Videos
Migrainous phenomena in systemic lupus erythematosus.
Arthritis and Rheumatism
|January 1, 1978
Summary
Systemic lupus erythematosus (SLE) patients experienced migraine-like symptoms, such as headaches and visual hallucinations, often during disease flares. These symptoms improved with SLE treatment, suggesting a link to vascular dysfunction in SLE.
Area of Science:
- Neurology
- Rheumatology
- Vascular Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Migraine is a common neurological disorder characterized by severe headaches and sensory disturbances.
- The relationship between SLE and migraine symptoms requires further elucidation.
Purpose of the Study:
- To investigate the occurrence and characteristics of migraine-like symptoms in patients with SLE.
- To explore the association between these symptoms and SLE disease activity.
- To evaluate the efficacy of different treatment modalities.
Main Methods:
- Observational study of eleven patients with SLE.
- Clinical assessment of headaches and visual disturbances.
- Correlation of symptom occurrence with SLE exacerbations and disease activity markers.
- Comparison of treatment responses to corticosteroids and conventional antimigraine therapies.
Main Results:
- Eleven SLE patients presented with migraine-like headaches and/or visual hallucinations.
- These symptoms frequently coincided with SLE disease flares and resolved as SLE activity decreased.
- Corticosteroids demonstrated superior efficacy over standard antimigraine treatments in managing headaches and scotomas in some patients.
Conclusions:
- Migraine-like phenomena can be a manifestation of systemic lupus erythematosus.
- Vascular dysfunction associated with SLE may precipitate these neurological symptoms.
- Treatment targeting SLE activity may be crucial for managing associated migraine-like symptoms.